Anvisa
Federal · Brazil · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
5402 Sia Trecho 5 Área Especial 57, Bras...Phone Number
+55 8133224999Website
www.anvisa.gov.brRevenue
$296.3 MillionIndustry
About Anvisa
Anvisa Org Chart
Is Anvisa your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Anvisa has new funding data
Earning: See what the market has to say on Anvisa recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Anvisa
Website visits: Recent activity has been detected on your website
Anvisa, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Anvisa had a recent Job posting/layoffs
Product Launch: Get notified when Anvisa launches new products
Check if Anvisa has recently received funding, and reach out quickly before it becomes old news!
Check out if Anvisa is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Anvisa as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Anvisa is experiencing very low activity levels compared to other companies in the Government sector.
What does this means?
Anvisa is drawing exceptional interest within the Government industry, suggesting notable developments or strong market momentum, learn more about Anvisa.
Anvisa Tech Stack
A closer look at the technologies used by Anvisa
Anvisa News & Media
CureMetrix secures ANVISA Registration Approval in Brazil for cmAngio®, detecting Breast Arterial Calcifications
The Artificial Intelligence (AI)--based deep learning algorithm helps radiologists identify breast arterial calcifications (BAC) in screening mammograms. SAN DIEGO, CA, UNITED STATES, March 14, 2024 /EINPresswire.com/ -- CureMetrix, a global leader in …ExoCoBio obtained 2 GMP Licenses for Exosome Biopharmaceuticals from Korea MFDS and for Hyaluronic Acid (HA) Dermal Fillers from Brazil ANVISA
ExoGMP™ is the world's largest exosome manufacturing facility in Osong, South Korea. Cellosome™ HA fillers are expected to be approved in 2023. ExoCoBio has all 3 types of GMP clearance for pharmaceuticals, medical devices, & cosmetics. SEOUL, South Korea, March 2, 2023 /PRNewswire/ --...Knight Therapeutics Announces Regulatory Submission for Tafasitamab in Brazil
MONTREAL, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltd., has submitted a marketing authorization application for tafasitamab in combination with lenalidomide to ANVISA, the Brazilian health regulatory agency, for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are not eligible for autoPearl’s Second Opinion® Receives Clearance in Brazil, Paving the Way for AI-Assisted Dental Radiology in the World’s Third-Largest Dental Market
LOS ANGELES--(BUSINESS WIRE)--Pearl, the leader in dental AI solutions, today announced that its Second Opinion® chairside clinical AI software has received clearance from the Brazilian Health Regulatory Agency (Anvisa), opening the door to AI-enabled dental care for dentists and patients across Brazil – the world’s third-largest dental market. Second Opinion® is the first and only chairside, FDA-cleared AI radiologic detection aid that can help dentists identify numerous common dental conditio
Top Federal Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Anvisa
ANVISA maintains that the use of such drugs is extremely serious and regulatory agencies all over the world must revise the rules on anorexigenic substances and implement a continuous safety control process.... Read More